182 related articles for article (PubMed ID: 33413746)
1. CT Texture Analysis: A Potential Biomarker for Evaluating KRAS Mutational Status in Colorectal Cancer.
Cao J; Wang GR; Wang ZW; Jin ZY
Chin Med Sci J; 2020 Dec; 35(4):306-314. PubMed ID: 33413746
[TBL] [Abstract][Full Text] [Related]
2. Analysis of KRAS Mutation Status Prediction Model for Colorectal Cancer Based on Medical Imaging.
Ren Z; Che J; Wu XW; Xia J
Comput Math Methods Med; 2021; 2021():3953442. PubMed ID: 34976107
[TBL] [Abstract][Full Text] [Related]
3. CT texture analysis for the prediction of KRAS mutation status in colorectal cancer via a machine learning approach.
Taguchi N; Oda S; Yokota Y; Yamamura S; Imuta M; Tsuchigame T; Nagayama Y; Kidoh M; Nakaura T; Shiraishi S; Funama Y; Shinriki S; Miyamoto Y; Baba H; Yamashita Y
Eur J Radiol; 2019 Sep; 118():38-43. PubMed ID: 31439256
[TBL] [Abstract][Full Text] [Related]
4. Radiomics Texture Features in Advanced Colorectal Cancer: Correlation with
Negreros-Osuna AA; Parakh A; Corcoran RB; Pourvaziri A; Kambadakone A; Ryan DP; Sahani DV
Radiol Imaging Cancer; 2020 Sep; 2(5):e190084. PubMed ID: 33778733
[TBL] [Abstract][Full Text] [Related]
5. Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?
Yang L; Dong D; Fang M; Zhu Y; Zang Y; Liu Z; Zhang H; Ying J; Zhao X; Tian J
Eur Radiol; 2018 May; 28(5):2058-2067. PubMed ID: 29335867
[TBL] [Abstract][Full Text] [Related]
6. CT textural analysis of hepatic metastatic colorectal cancer: pre-treatment tumor heterogeneity correlates with pathology and clinical outcomes.
Lubner MG; Stabo N; Lubner SJ; del Rio AM; Song C; Halberg RB; Pickhardt PJ
Abdom Imaging; 2015 Oct; 40(7):2331-7. PubMed ID: 25968046
[TBL] [Abstract][Full Text] [Related]
7. Quantitative CT texture analysis for evaluating histologic grade of urothelial carcinoma.
Zhang GM; Sun H; Shi B; Jin ZY; Xue HD
Abdom Radiol (NY); 2017 Feb; 42(2):561-568. PubMed ID: 27604896
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive KRAS mutation estimation in colorectal cancer using a deep learning method based on CT imaging.
He K; Liu X; Li M; Li X; Yang H; Zhang H
BMC Med Imaging; 2020 Jun; 20(1):59. PubMed ID: 32487083
[TBL] [Abstract][Full Text] [Related]
9. Role of MR texture analysis in histological subtyping and grading of renal cell carcinoma: a preliminary study.
Goyal A; Razik A; Kandasamy D; Seth A; Das P; Ganeshan B; Sharma R
Abdom Radiol (NY); 2019 Oct; 44(10):3336-3349. PubMed ID: 31300850
[TBL] [Abstract][Full Text] [Related]
10. Construction of prediction model for KRAS mutation status of colorectal cancer based on CT radiomics.
Cao Y; Zhang J; Huang L; Zhao Z; Zhang G; Ren J; Li H; Zhang H; Guo B; Wang Z; Xing Y; Zhou J
Jpn J Radiol; 2023 Nov; 41(11):1236-1246. PubMed ID: 37311935
[TBL] [Abstract][Full Text] [Related]
11. Preoperative prediction of perineural invasion and KRAS mutation in colon cancer using machine learning.
Li Y; Eresen A; Shangguan J; Yang J; Benson AB; Yaghmai V; Zhang Z
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3165-3174. PubMed ID: 32779023
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of using computed tomography texture analysis parameters as imaging biomarkers for predicting risk grade of gastrointestinal stromal tumors: comparison with visual inspection.
Choi IY; Yeom SK; Cha J; Cha SH; Lee SH; Chung HH; Lee CM; Choi J
Abdom Radiol (NY); 2019 Jul; 44(7):2346-2356. PubMed ID: 30923842
[TBL] [Abstract][Full Text] [Related]
13. Relationship Between 18F-FDG PET/CT Scans and KRAS Mutations in Metastatic Colorectal Cancer.
Kawada K; Toda K; Nakamoto Y; Iwamoto M; Hatano E; Chen F; Hasegawa S; Togashi K; Date H; Uemoto S; Sakai Y
J Nucl Med; 2015 Sep; 56(9):1322-7. PubMed ID: 26135109
[TBL] [Abstract][Full Text] [Related]
14. Unresectable pancreatic ductal adenocarcinoma: Role of CT quantitative imaging biomarkers for predicting outcomes of patients treated with chemotherapy.
Cheng SH; Cheng YJ; Jin ZY; Xue HD
Eur J Radiol; 2019 Apr; 113():188-197. PubMed ID: 30927946
[TBL] [Abstract][Full Text] [Related]
15. Development of a dual-energy spectral CT based nomogram for the preoperative discrimination of mutated and wild-type KRAS in patients with colorectal cancer.
Cao Y; Zhang G; Bao H; Zhang S; Zhang J; Zhao Z; Zhang W; Li W; Yan X; Zhou J
Clin Imaging; 2021 Jan; 69():205-212. PubMed ID: 32920468
[TBL] [Abstract][Full Text] [Related]
16. The value of
Oner AO; Budak ES; Yıldırım S; Aydın F; Sezer C
Hell J Nucl Med; 2017; 20(2):160-165. PubMed ID: 28697193
[TBL] [Abstract][Full Text] [Related]
17. Could texture features from preoperative CT image be used for predicting occult peritoneal carcinomatosis in patients with advanced gastric cancer?
Kim HY; Kim YH; Yun G; Chang W; Lee YJ; Kim B
PLoS One; 2018; 13(3):e0194755. PubMed ID: 29596522
[TBL] [Abstract][Full Text] [Related]
18. Correlation between PET/CT parameters and KRAS expression in colorectal cancer.
Chen SW; Chiang HC; Chen WT; Hsieh TC; Yen KY; Chiang SF; Kao CH
Clin Nucl Med; 2014 Aug; 39(8):685-9. PubMed ID: 24978328
[TBL] [Abstract][Full Text] [Related]
19. Characterizing MRI features of rectal cancers with different KRAS status.
Xu Y; Xu Q; Ma Y; Duan J; Zhang H; Liu T; Li L; Sun H; Shi K; Xie S; Wang W
BMC Cancer; 2019 Nov; 19(1):1111. PubMed ID: 31727020
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of F-18 FDG PET/CT for prediction of KRAS mutation in colorectal cancer patients: a systematic review and meta-analysis.
Kim SJ; Pak K; Kim K
Abdom Radiol (NY); 2019 May; 44(5):1703-1711. PubMed ID: 30603881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
